Strategic News Watch • August 4, 2026 Daily Biopharma Digest – August 4, 2026 August 4, 2026 Pfizer axed two clinical-stage obesity programs — including… Strategic News Watch Membership Required You must be a Strategic News Watch member to access this content. Join Now Already a member? Log in here Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription.